Iron aggravates the depressive phenotype of stressed mice by compromising the glymphatic system
Robinson S, Kwan Z, Tang MM
Both the ADA and ACP emphasize medical nutrition therapy, physical activity, and behavioral support as cornerstones of diabetes and weight management
Combination Weight Loss (CagriSema) Extensive Research The Phase 3 REDEFINE 1 trial demonstrated that CagriSema (cagrilintide 2.4 mg plus semaglutide 2.4 mg) produced mean weight loss of 20.4% at 68 weeks in 3,417 adults with obesity or overweight without diabetes, compared to 14.9% with semaglutide alone, 11.5% with cagrilintide alone, and 3.0% with placebo
Safety Profile: Ipamorelin Established Adverse Effects Ipamorelin's most common adverse effects at therapeutic doses are mild and include injection-site erythema, transient headache, flushing, and water retention during the first 1 to 2 weeks as GH levels rise